Article de revue
Three decades of hepatitis B control with vaccination
Hepatitis B virus (HBV) continues to represent a major health problem and can lead to acute liver failure, acute hepatitis, chronic carriership, chronic hepatitis of HBV, liver cirrhosis, liver cancer, liver transplantation and death. There is a marked difference in the geographic distribution of carriers. More than 240 million people worldwide are chronic HBV carriers. Mother-to-child transmission remains the most important mechanism of infection in countries with a high prevalence of HBV. Percutaneous/parenteral transmission and unsafe sexual practices are important mode of spread transmission of HBV in other countries. Vaccination against HBV is the gold measure for primary prevention and control of the disease. Currently, 179 countries have added HBV vaccination to their routine vaccination programs with great results. Neonatal immunization with HBV vaccine has been one of the most highly effective measures in public health and the first anti-cancer program to be launched. In this paper we review the achievements for the last three decades.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
World J Hepatol
Volume
18
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Hépatite B
Pays
- Chine
- Gambie
- Espagne
Mots-clés
- Coverage monitoring
- Performance monitoring
Régions de l'OMS
- Région africaine
- Région européenne
- Région du Pacifique occidental